Osteoporosis is a chronic disease that is characterized by a loss of bone density, which mainly affects the microstructure of the bones due to a decrease in bone mass, thereby making them more fragile and susceptible to fractures. Osteoporosis is currently considered one of the pandemics of the 21st century, affecting around 200 million people. Its most serious consequence is an increased risk of bone fractures, thus making osteoporosis a major cause of disability and even premature death in the elderly. In this review, we discuss its causes, the biochemical mechanisms of bone regeneration, risk factors, pharmacological treatments, prevention and the effects of diet, focusing in this case on compounds present in a diet that could have palliative and preventive effects and could be used as concomitant treatments to drugs, which are and should always be the first option. It should be noted as a concluding remark that non-pharmacological treatments such as diet and exercise have, or should have, a relevant role in supporting pharmacology, which is the recommended prescription today, but we cannot ignore that they can have a great relevance in the treatment of this disease.
Osteoporosis is a chronic disease that is characterized by a loss of bone density, mainly affecting the microstructure of the bones, due to a decrease in bone mass, thereby making them more fragile and susceptible to fractures. Osteoporosis is currently considered one of the pandemics of the 21st century, affecting around 200 million people. Its most serious consequence is an increased risk of bone fractures, thus making osteoporosis a major cause of disability and even premature death in the elderly. In this review we discuss causes, biochemical mechanisms of bone regeneration, risk factors, pharmacological treatments, prevention and effects of diet, focusing in this case on compounds present in the diet that could have palliative and preventive effects and could be used as concomitant treatments to drugs, which are and should always be the first option. It should be noted as concluding remarks that non-pharmacological treatments such as diet and exercise have, or should have, a relevant role in supporting pharmacology, which is the recommended prescription today, but we cannot ignore that they can have a great relevance in the treatment of this disease.
Background: Time‐restricted eating (TRE) limits food intake to a specific daily window and has gained popularity, showing modest benefits for cardiometabolic health. However, perspectives and experiences from adults and healthcare professionals about TRE remain underexplored but are vital for successful implementation in research and clinical practice. Objective: To synthesize qualitative evidence on participants' and healthcare professionals' experiences and perceptions of TRE, with a gender‐based analytical lens. Methods: A systematic search was conducted on four databases from their inception until March 2025, searching for studies reporting qualitative analysis of the perceptions and experiences associated with TRE in adults and healthcare professionals. Methodological quality was appraised using the CASP checklist. Thematic synthesis was applied to extract overarching themes, with additional gender‐based analysis. Confidence in the findings was assessed using the GRADE‐CERQual approach. Results: Thirteen articles including 225 participants (aged between 18 and 74 years), of which 22 were health professionals and dietitians were included. Three themes were found: motivation; barriers and facilitators, including three subthemes in each: biological, psychological and socio‐cultural. Women's perspectives were commonly related to disappointment with previous diet and body dissatisfaction as motivators, food craving and emotional eating behaviors as barriers, and improvement of healthy eating habits and hunger control as facilitators. Otherwise, men were more motivated by managing appetite with shorter eating windows and found routine and day planning as key facilitators. Conclusion: Perceptions and experiences of TRE are shaped by diverse motivators and challenges. Tailored, gender‐sensitive approaches to support TRE integration in clinical practice are needed. PROSPERO Registry Number: CRD420250649633